Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder.

Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter LR Jr.

Psychiatry Res. 1998 Nov 9;84(1):1-6.

PMID:
9870412
2.

Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.

Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME.

Arch Gen Psychiatry. 1996 Feb;53(2):109-13.

PMID:
8629886
3.

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, Rapoport SI, Rapoport JL, Grady CL.

Arch Gen Psychiatry. 1992 Sep;49(9):690-4.

PMID:
1514873
4.

Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder.

Rauch SL, Dougherty DD, Cosgrove GR, Cassem EH, Alpert NM, Price BH, Nierenberg AA, Mayberg HS, Baer L, Jenike MA, Fischman AJ.

Biol Psychiatry. 2001 Nov 1;50(9):659-67.

PMID:
11704072
5.

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR Jr.

Arch Gen Psychiatry. 2002 Mar;59(3):250-61.

PMID:
11879163
6.

Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder.

Yamanishi T, Nakaaki S, Omori IM, Hashimoto N, Shinagawa Y, Hongo J, Horikoshi M, Tohyama J, Akechi T, Soma T, Iidaka T, Furukawa TA.

Psychiatry Res. 2009 Jun 30;172(3):242-50. doi: 10.1016/j.pscychresns.2008.07.004. Epub 2009 Apr 5.

PMID:
19346109
7.

Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.

Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, Vallejo J.

J Clin Psychiatry. 2001 Jul;62(7):535-40.

PMID:
11488364
8.
9.

Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.

Apostolova I, Block S, Buchert R, Osen B, Conradi M, Tabrizian S, Gensichen S, Schröder-Hartwig K, Fricke S, Rufer M, Weiss A, Hand I, Clausen M, Obrocki J.

Psychiatry Res. 2010 Nov 30;184(2):105-16. doi: 10.1016/j.pscychresns.2010.08.012. Epub 2010 Oct 14.

PMID:
20947317
10.

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.

Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE.

Arch Gen Psychiatry. 1987 Mar;44(3):211-8. Erratum in: Arch Gen Psychiatry 1987 Sep;44(9):800.

PMID:
3493749
11.

Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently.

Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, Huang SC, Wu HM, Au SC, Baxter LR Jr.

Biol Psychiatry. 2001 Aug 1;50(3):159-70.

PMID:
11513814
12.

Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine.

Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME, Huang SC, Wu HM, Maidment K, Baxter LR Jr.

Psychiatry Res. 1999 Oct 11;91(3):127-39.

PMID:
10641577
13.

Regional cerebral glucose metabolism of women with trichotillomania.

Swedo SE, Rapoport JL, Leonard HL, Schapiro MB, Rapoport SI, Grady CL.

Arch Gen Psychiatry. 1991 Sep;48(9):828-33.

PMID:
1929773
14.

Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.

Kwon JS, Kim JJ, Lee DW, Lee JS, Lee DS, Kim MS, Lyoo IK, Cho MJ, Lee MC.

Psychiatry Res. 2003 Jan 20;122(1):37-47.

PMID:
12589881
15.

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.

Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, et al.

Arch Gen Psychiatry. 1992 Sep;49(9):681-9.

PMID:
1514872
16.

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.

Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM.

Arch Gen Psychiatry. 1990 Sep;47(9):840-8.

PMID:
2393342
17.

[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment.

Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, Bellodi L, Smeraldi E, Fazio F.

Br J Psychiatry. 1995 Feb;166(2):244-50.

PMID:
7728370
18.

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.

Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI, Rapoport JL.

Arch Gen Psychiatry. 1989 Jun;46(6):518-23.

PMID:
2786402
19.

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder.

Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, Phelps ME, Baxter LR Jr.

Neuropsychopharmacology. 1999 Dec;21(6):683-93.

20.

Obsessive-compulsive disorder.

Insel TR.

Psychiatr Clin North Am. 1985 Mar;8(1):105-17. Review.

PMID:
3887336
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk